HCA

HCA Healthcare, Inc. - 10-Q Summary (Q3 2006)

Business Context and Reporting Period

This report covers the quarterly period ended September 30, 2006. HCA Inc. is a holding company owning and operating 172 hospitals and 95 freestanding surgery centers across 21 U.S. states, England, and Switzerland. The company operates in a single line of business: operating hospitals and related health care entities. A significant portion of patient revenues (approximately 26% for the nine months ended Sept 30, 2006) is derived from Medicare and Medicaid programs.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Decline: Net income decreased 14.6% in Q3 2006 and 16.9% for the nine-month period compared to the prior year. This was driven by increased operating costs, higher interest expense, and the adoption of new accounting standards for share-based compensation.
• Revenue Growth: Revenues increased 3.1% in Q3 and 3.9% for the nine months. Same-facility revenues grew 5.4% in Q3, driven by a 6.4% increase in revenue per equivalent admission, partially offset by a 0.9% decline in same-facility equivalent admissions.
• Expense Pressures: Salaries and benefits increased to 41.8% of revenues in Q3 2006 (from 41.2% in 2005). The provision for doubtful accounts rose to 10.9% of revenues (from 10.3%), reflecting higher uninsured discounts ($277 million in Q3 2006 vs. $241 million in Q3 2005).
• Interest Expense: Interest expense increased 25% in Q3 2006 ($200 million vs. $160 million) due to higher average debt balances ($11.4 billion vs. $9.3 billion) and rising interest rates.
• Unusual Items: Q3 2006 included $41 million in gains on sales of facilities and $9 million in transaction costs related to a proposed merger. Q3 2005 included $33 million in hurricane-related costs (Katrina/Rita) and a $22 million tax benefit from repatriating foreign earnings.

Guidance, Outlook, and Risks

• Merger Agreement: On July 24, 2006, HCA entered into a merger agreement to be acquired by a consortium of private equity firms (Bain Capital, KKR, Merrill Lynch) for $51.00 per share in cash. The transaction is expected to close in Q4 2006, subject to shareholder approval and regulatory conditions. The company is currently tendering $1.36 billion of its debt.
• Capital Expenditures: Capital expenditures for 2006 are expected to approximate $1.85 billion. Projects under construction have estimated additional costs of $2.2 billion over the next five years.
• Legal and Regulatory Risks:
  • IRS Disputes: The IRS is seeking an additional $662 million in taxes, interest, and penalties regarding returns from 1990–2004. Management believes provisions are adequate.
  • Government Investigations: Ongoing investigations by the SEC and the U.S. Attorney for the Southern District of New York regarding trading in HCA securities.
  • Merger Litigation: Multiple class-action lawsuits have been filed challenging the merger process and consideration.
  • Regulatory Changes: Risks associated with changes in Medicare/Medicaid reimbursement rates and the Deficit Reduction Act of 2005 (DEFRA 2005).
• Insurance Subsidiary: The company's wholly-owned insurance subsidiary holds $2.464 billion in investments. Net unrealized gains declined to $105 million as of Sept 30, 2006.

Investor Verification Checklist

• Merger Completion: Verify the status of shareholder approval and regulatory clearance for the $51.00/share buyout, as failure to close could impact stock price and liquidity.
• Debt Refinancing: Monitor the success of the tender offer for $1.36 billion in notes and the ability to secure new credit facilities to fund the merger.
• Uninsured Discount Impact: Assess the sustainability of the 14.7% provision for doubtful accounts (adjusted for uninsured discounts) and its effect on future margins.
• IRS Resolution: Track the outcome of the $662 million tax dispute and any potential cash outflows or reserve adjustments.
• Volume Trends: Confirm whether the decline in same-facility equivalent admissions (-0.9% in Q3) is a temporary trend or indicative of broader market share loss.